A South African organisation received a generous donation to support individuals with Cystic Fibrosis while addressing medication accessibility challenges in the country.
Pretoria, South Africa (07 May 2024) – A Cape Town-based organisation has received a generous donation of R400,000 to support individuals living with Cystic Fibrosis (CF) and address the significant challenge of medication accessibility in South Africa.
Breathtaking Fundraising, a non-profit that assists individuals with CF in SA to access medication and raise awareness about this debilitating condition, received the donation through a golf day event at Wingate Golf Course in Pretoria by donors TRX Electronics and Pachas Restaurant on 15 March 2024.
The funds will go towards much-needed support for individuals living with CF who can only access life-changing medication from Argentina to help manage the disease.
CF is an inherited genetic disorder that thickens mucus in the body, causing blockages in vital organs such as the lungs and pancreas. It can lead to recurrent lung infections and irreversible damage, as well as hamper digestion and nutrient absorption. Symptoms and health issues due to CF are wide-ranging and may include frequent sinus infections, diabetes, osteoporosis, arthritis, infertility and liver problems.
Around 600 patients have been diagnosed with CF in SA; however, due to the complex nature of the disease and a high rate of misdiagnosis, it is estimated that at least 4,700 people may be living with the disease. It is a lifelong condition for which there is no cure, with an average life expectancy of under 21 years. Until 2019, doctors could only treat the symptoms of the disease. However, given the life-shortening and debilitating health effects, treatments such as CFTR modulator therapies were developed by a US-based company, Vertex Pharmaceuticals, which drastically improved and extended the lives of patients. However, these therapies are not registered in SA.
A lawsuit is underway in SA against Vertex to allow patients access to medication at an affordable cost.
A recent announcement by the South Africa Cystic Fibrosis Association (SACFA) reveals that the modulator drug Trifakta is now available to Discovery Medical Aid members; however, this still leaves a significant portion of South Africans without access to treatment.
Managing Director of Breathtaking Fundraising NPC Maré Smit, who lives with CF, said, “We deeply appreciate the support from companies like TRX Electronics and Pachas, who are instrumental in advancing our mission to improve the lives of those impacted by Cystic Fibrosis. We believe that everyone should have access to this life-saving treatment for improved quality of life and extended life expectancy.”
Let’s join hands and work together to support individuals battling CF, ensuring that each person receives the care and assistance necessary for their well-being because it’s through our collective compassion that we cultivate hope and break down barriers, paving the way for a brighter tomorrow.
by 